Feng-Zhu Wang | Host-Pathogen Interactions | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Feng-Zhu Wang | Host-Pathogen Interactions | Best Researcher Award

Assoc. Prof. Dr. Feng-Zhu Wang , Sun Yat-sen University , China

Dr. Feng-Zhu Wang is an Associate Professor at the School of Life Science, Sun Yat-sen University, China. He earned his Ph.D. in Botany from the same institution under Prof. Shi Xiao and has focused his research on plant immunity and mycorrhizal symbiosis. After his Ph.D., Dr. Wang pursued postdoctoral research with Prof. Jian-Feng Li, contributing significantly to CRISPR-based gene editing and plant-pathogen interactions. With over 7 co-first-author publications and experience as a corresponding author, he demonstrates both innovation and leadership in plant biology. His research has been published in esteemed journals, including Nature Communications and Trends in Plant Science. Now leading his lab, Dr. Wang is committed to advancing agricultural biotechnology through molecular tools and sustainable practices. His achievements in plant immunity, stress tolerance, and CRISPR tools place him as a key figure in contemporary plant science.

Publication Profile:

Scopus

✅ Strengths for the Award:

  • 🧬 Extensive expertise in plant immunity and symbiotic relationships, critical for sustainable agriculture.

  • 🧪 Consistent high-impact publications in journals like Nature Communications and Trends in Plant Science.

  • 💡 Developed innovative tools like dual-function CRISPR systems, highlighting technological creativity.

  • 👩‍🏫 Strong academic foundation with continuous roles in postdoc, research, and teaching, demonstrating leadership and growth.

  • ✍️ Serves as corresponding or co-first author in multiple works, showing project ownership and contribution depth.

🔍 Areas for Improvement:

  • 🌍 Could benefit from international collaborations to increase global visibility.

  • 🎓 Expanding mentorship activities and outreach could enhance influence on future scientists.

  • 🗣️ More presence in conferences or workshops would elevate public engagement and field leadership.

🎓 Education:

Feng-Zhu Wang completed both his undergraduate and doctoral studies at Sun Yat-sen University, China, a prestigious institution known for life science research. He earned a B.Sc. in Biotechnology between 2009 and 2013, where he developed foundational knowledge in molecular biology and genetics. His Ph.D., pursued from 2013 to 2018 in the Department of Botany under Prof. Shi Xiao, focused on plant stress responses, particularly involving immunity and symbiosis. His educational journey emphasized hands-on lab techniques, scientific writing, and experimental design. Through intensive academic training and mentorship, Dr. Wang cultivated skills in gene regulation, CRISPR-Cas systems, and plant-microbe interactions. This solid academic foundation provided the groundwork for his impactful research contributions and prepared him for advanced exploration into genetic mechanisms driving plant resistance to both biotic and abiotic stresses.

💼 Experience:

Dr. Feng-Zhu Wang’s academic career is firmly rooted in Sun Yat-sen University, where he has continuously advanced through roles in education and research. After completing his Ph.D. in 2018, he undertook postdoctoral training from 2018 to 2024 under Prof. Jian-Feng Li, focusing on advanced molecular biology tools, plant-pathogen interactions, and CRISPR gene editing. He contributed to developing innovative dual-function CRISPR systems and molecular assays for plant biology. In May 2024, he was appointed Associate Professor in the Department of Biology. His experience spans project leadership, scientific writing, collaboration, and mentoring young researchers. As both a co-first and corresponding author on multiple papers, Dr. Wang demonstrates a proactive role in scientific innovation and dissemination. His experience reflects a seamless integration of research development, experimental practice, and academic progression within one of China’s leading universities.

🔬 Research Focus:

Dr. Wang’s research revolves around two main areas: plant immunity mechanisms and mycorrhizal symbiosis, both crucial to improving plant resilience and productivity. He investigates how plants detect and defend against fungal pathogens through receptor-mediated signaling pathways and how beneficial fungi assist plants in nutrient uptake and stress tolerance. His work also dives deep into genetic engineering using CRISPR-Cas systems, developing tools for efficient multigene editing and Cas9-free selection in model organisms like Arabidopsis thaliana. By combining bioinformatics, molecular genetics, and cell biology, Dr. Wang aims to understand how immune responses are regulated and how plants can balance defense and symbiosis. This dual focus supports sustainable agriculture and provides insight into fundamental plant biology. His contributions are not only theoretical but also technological, offering tools that can be used in practical breeding and crop enhancement strategies worldwide.

📚 Publications Top Notes:

  1. 🧪 Nepenthes chitinase NkChit2b-1 confers broad-spectrum resistance to chitin-containing pathogens and insects in plants – Advanced Biotechnology, 2025

  2. 🧬 A dual-function selection system enables positive selection of multigene CRISPR mutants and negative selection of Cas9-free progeny in Arabidopsis – aBIOTECH, 2024

  3. 🔍 Hidden prevalence of deletion-inversion bi-alleles in CRISPR-mediated deletions of tandemly arrayed genes in plants – Nature Communications, 2023

  4. 🍄 Hide-and-seek: Chitin-triggered plant immunity and fungal counterstrategies – Trends in Plant Science, 2020

  5. 🔗 Split Nano luciferase complementation for probing protein-protein interactions in plant cells – Journal of Integrative Plant Biology, 2020

  6. 🌾 Alternative splicing and translation play important roles in hypoxic germination in rice – Journal of Experimental Botany, 2019

  7. 💧 Natural variation in the promoter of rice Calcineurin B-like Protein10 affects flooding tolerance during seed germination among rice subspecies – Plant Journal, 2018

  8. ☣️ OsARM1, an R2R3 MYB transcription factor, is involved in regulation of the response to arsenic stress in rice – Frontiers in Plant Science, 2017

🔚 Conclusion:

Dr. Feng-Zhu Wang stands out as a promising and accomplished researcher. With an impressive portfolio of impactful publications and strong academic roots in plant biology, they are highly suitable for the Best Researcher Award. A few enhancements in outreach and collaboration could further elevate their global scientific profile.

Raul Valenzuela | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Raul Valenzuela | Cancer Cell Biology | Best Researcher Award

Assist. Prof. Dr. Raul Valenzuela , MD Anderson Cancer Center , United States

Dr. Raul F. Valenzuela Perez is a highly accomplished Assistant Professor of Musculoskeletal Imaging at The University of Texas MD Anderson Cancer Center. With over two decades of medical experience, he combines expertise in radiology, oncology, and advanced imaging techniques. Originating from Chile, Dr. Valenzuela earned his MD from Universidad de Chile and pursued advanced training in health administration and imaging sciences. His global perspective and collaborative research efforts have made him a prominent figure in musculoskeletal tumor imaging. He is board-certified in radiology in both the U.S. and Chile and is actively licensed in Texas and Florida. Dr. Valenzuela’s dedication to oncologic imaging, radiomics, and MRI innovations has resulted in numerous peer-reviewed publications, especially in the field of sarcoma imaging. Through ongoing work in developing and validating novel imaging biomarkers, he continues to shape the future of cancer diagnostics and personalized treatment approaches.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Prolific Research Output 📚
    Dr. Valenzuela has published extensively in high-impact journals like Scientific Reports, JCO Clinical Cancer Informatics, and Journal of Radiology & Oncology, with recent work in 2023–2025 focusing on radiomics, MRI biomarkers, and musculoskeletal oncology.

  2. Innovation in Imaging Techniques 💡
    He has pioneered the use of contrast-enhanced susceptibility-weighted imaging (CE-SWI) and quantitative diffusion-weighted MRI to evaluate soft tissue sarcomas and treatment response — advancing imaging beyond traditional RECIST criteria.

  3. Collaborative Multidisciplinary Work 🤝
    Dr. Valenzuela consistently co-authors with surgical oncologists, pathologists, and radiologists, highlighting his collaborative research approach that bridges disciplines.

  4. International Clinical Credibility 🌎
    He is licensed in the U.S. (Texas & Florida) and Chile, and board-certified in both American and Chilean radiology boards, reflecting his global expertise and trust in varied medical systems.

  5. Academic Leadership at MD Anderson 🎓
    As an Assistant Professor at one of the world’s top cancer centers, he contributes to education, clinical care, and high-level cancer imaging research.

⚙️ Areas for Improvement:

  1. Recognition and Awards Disclosure 🏅
    While the publication record is impressive, public listing of prior individual awards, fellowships, or grants would strengthen his profile further for award consideration.

  2. Principal Investigator Roles 🧪
    Although highly involved in collaborative projects, leading major multi-center trials or imaging consortia as principal investigator would elevate his leadership status.

  3. Expanded Public Science Communication 🗣️
    Increasing outreach via conferences, keynote talks, or educational platforms (like webinars or radiology workshops) could enhance his visibility in the broader scientific community.

🎓 Education:

Dr. Raul F. Valenzuela Perez holds an MD from Universidad de Chile (1993), where he laid the foundation for his distinguished medical and academic career. Alongside his medical training, he pursued further specialization in healthcare management, earning two certificates from the University of Chile Business School: one in Business and Health Administration (2003) and another in Process Management and Health Administration (2005). This unique blend of medical and administrative education empowers Dr. Valenzuela with a strategic understanding of healthcare systems and leadership. His academic journey highlights a commitment to continuous learning and cross-disciplinary excellence. As a thought leader in radiologic sciences, Dr. Valenzuela has integrated his business knowledge with clinical expertise to enhance imaging workflows and patient-centered care, especially in high-impact cancer institutions like MD Anderson. His education reflects both clinical proficiency and managerial insight, laying the groundwork for his contributions to musculoskeletal oncology imaging.

🏥 Experience:

Since September 2019, Dr. Valenzuela has served as an Assistant Professor in Musculoskeletal Imaging at The University of Texas MD Anderson Cancer Center, one of the world’s leading cancer research institutions. Prior to his tenure in the U.S., he developed a robust clinical background in Chile, where he practiced and taught radiology. With licenses from the Texas Medical Board, Florida Medical Board, and Chilean Medical Association, his clinical credentials span internationally. He is also certified by the American Board of Radiology and the Chilean Radiology Board. At MD Anderson, Dr. Valenzuela plays a key role in advancing diagnostic imaging for musculoskeletal tumors, particularly soft tissue sarcomas. His responsibilities include patient care, teaching, research, and contributing to the development of advanced imaging protocols. Known for his collaborative style and interdisciplinary approach, he is a respected mentor and a valued contributor in the field of cancer imaging.

🏅 Awards and Honors:

While specific named awards are not detailed in the provided data, Dr. Raul F. Valenzuela Perez’s growing publication record, leading research in radiomics, and collaborative work at MD Anderson suggest a strong reputation in his field. His continuous publication in high-impact journals, such as Scientific Reports, JCO Clinical Cancer Informatics, and Journal of Radiology & Oncology, indicate recognition by peers and ongoing contributions to advancing cancer imaging. His role in multidisciplinary research teams and innovative use of advanced MRI techniques position him as a strong candidate for awards like Best Researcher. His efforts in improving imaging criteria beyond RECIST and validating AI-based radiomic frameworks show both vision and leadership. Though a detailed list of awards isn’t cited, his contributions to musculoskeletal oncology, particularly in sarcoma treatment response evaluation, reflect a track record of academic excellence and clinical impact, meriting honor and distinction in his specialty.

🔬 Research Focus:

Dr. Valenzuela’s primary research focus lies in advanced imaging for musculoskeletal oncology, particularly the integration of radiomics, perfusion-weighted MRI, and contrast-enhanced susceptibility-weighted imaging (CE-SWI) for tumor characterization and treatment monitoring. His work is centered on improving diagnosis and predicting response in soft-tissue sarcomas, such as undifferentiated pleomorphic sarcoma (UPS) and desmoid fibromatosis. He actively collaborates on multi-institutional studies, applying quantitative imaging biomarkers and AI-driven radiomic models to identify tumor behavior patterns and personalize therapy. A key aspect of his research is the evaluation of multiparametric MRI features, including diffusion-weighted and dynamic contrast-enhanced imaging. His publications reveal a commitment to pushing boundaries in functional imaging and improving imaging response criteria beyond traditional RECIST methods. Through his research, Dr. Valenzuela aims to contribute to precision medicine in oncology, bridging radiology and data science to enhance patient outcomes and streamline therapeutic decision-making.

📚 Publications Top Notes:

  1. 🧠 Perfusion-weighted imaging features predicting UPS treatment response – Sci Rep, 2024

  2. 🧬 Radiomics by diffusion-weighted MRI for extremity UPS prediction – J Radiol Oncol, 2024

  3. 🧲 Contrast-enhanced SWI for musculoskeletal oncologic pathology – J Radiol Oncol, 2024

  4. 💉 Perfusion imaging of the musculoskeletal system – Magn Reson Imaging Clin N Am, 2024

  5. 🤖 Cancer radiomic and perfusion imaging automated framework – JCO Clin Cancer Inform, 2024

  6. 🧠 Idiopathic intracranial hypertension: MRI vs venous sinus pressure – Rev Chil Radiol, 2023

  7. 📊 CE-SWI in desmoid fibromatosis response assessment – Tumor Discov, 2023

  8. 📈 Multiparametric MRI for treatment and recurrence in sarcoma – J Radiol Oncol, 2023

  9. 🔍 ADC map-based radiomics for sacral tumor differentiation – JCO Precis Oncol, 2023

  10. 📐 Advanced imaging in musculoskeletal oncology (ABASTI Part I) – Semin Ultrasound CT MR, 2021

  11. 🧪 Radiomic features of CE-SWI in UPS treatment response – JCO Clin Cancer Inform, 2025

📝 Conclusion:

Dr. Raul F. Valenzuela Perez is a highly deserving candidate for the Best Researcher Award. His innovative contributions to musculoskeletal oncologic imaging, especially in applying radiomic models and advanced MRI techniques, place him at the forefront of translational cancer imaging. His interdisciplinary collaborations and growing body of work have strong clinical impact, particularly for sarcoma management.

With additional visibility through PI roles and recognition through formal honors, Dr. Valenzuela’s already impressive profile is on a trajectory toward international distinction. Based on the current accomplishments and ongoing impactful research, he is highly recommended for this award.

Noura Hussein Abdel Hamid | Cell Structure Analysis | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Noura Hussein Abdel Hamid | Cell Structure Analysis | Best Researcher Award

Assist. Prof. Dr. Noura Hussein Abdel Hamid , Zagazig University , Egypt

Dr. Noura Hussein Abedel Hamid Mekawy is a dedicated Egyptian medical academic with extensive expertise in Histology and Cell Biology. Born on April 18, 1981, she graduated with an M.B.B.Ch. from Zagazig University in 2006, followed by a Master’s (2012) and an M.D. (2017) in Histology and Cell Biology from the same institution. Currently, she serves as a Lecturer at Zagazig University’s Faculty of Medicine. Her academic journey is complemented by her passion for medical education, microscopy, and molecular research. Dr. Mekawy has contributed to the field with multiple publications in reputable scientific journals, focusing on histopathological and immunohistochemical studies. She is a member of the Egyptian Society of Histology and Cytology and has completed professional training in self-evaluation and quality assurance in higher education. Her commitment to scientific advancement and education has established her as a respected figure in medical academia.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Extensive Research Background
    Dr. Mekawy has authored and co-authored 10 peer-reviewed publications, focusing on histopathology, immunohistochemistry, toxicology, and therapeutic interventions in experimental models.

  2. Specialization in a Vital Medical Field
    Her focus on Histology and Cell Biology is crucial for understanding disease mechanisms and developing new treatment strategies.

  3. Academic Progression & Teaching Role
    She has shown consistent career advancement from Demonstrator to Lecturer, demonstrating leadership and commitment in academia.

  4. Diverse Research Themes
    Her work explores the toxicological impacts of nanoparticles, pharmaceuticals, and environmental exposures, as well as the protective effects of antioxidants and stem cells—offering a well-rounded scientific profile.

  5. Professional Engagement
    Active member of Egyptian Society of Histology and Cytology and Medical Professions Syndicate, and involved in scientific conferences and training workshops.

  6. Methodological Strength
    Her skills in light/electron microscopy and immunohistochemical techniques indicate deep technical expertise.

⚙️ Areas for Improvement:

  1. Expand to International Collaborations
    Engaging in collaborative research with international institutions can increase visibility and impact.

  2. Publication in Higher Impact Journals
    While she has multiple publications, targeting high-impact Q1 journals can elevate the academic value of her research.

  3. Grant Funding & Project Leadership
    Applying for external research grants and leading funded projects would further enhance her research profile.

  4. Clinical Translation
    Bridging her findings from animal studies to clinical or translational research can broaden applicability.

🎓 Education:

Dr. Noura Mekawy earned her M.B.B.Ch. degree in Medicine and General Surgery from Zagazig University in October 2006, graduating with an excellent grade. Her strong academic foundation led her to pursue postgraduate studies in Histology and Cell Biology. In May 2012, she was awarded a Master’s degree with a thesis titled “The Effect of Maternal Exposure to Di (2-ethylhexyl) phthalate on The Lung of Albino Rat Offspring (Histological and Immunohistochemical Study).” She continued her academic progression by earning her M.D. in Basic Medical Sciences (Histology and Cell Biology) in January 2017. Throughout her studies, Dr. Mekawy demonstrated outstanding academic performance and developed a deep interest in cellular biology and histopathology. Her educational background reflects her commitment to advancing medical science through both practical research and academic instruction.

🧪 Experience:

Dr. Noura Mekawy began her academic career as a Demonstrator in the Histology and Cell Biology Department at Zagazig University in August 2008. She served in this role until May 2012, when she was promoted to Assistant Lecturer. In January 2017, following the completion of her M.D., she assumed the position of Lecturer in the same department. With over 15 years of experience in teaching and laboratory work, Dr. Mekawy has become proficient in histological techniques, immunohistochemistry, and electron microscopy. She is also skilled in data analysis using SPSS and Microsoft Office tools. Her responsibilities include teaching, supervising research projects, and contributing to curriculum development. Additionally, she has participated in educational quality assurance workshops and continues to mentor students and junior faculty members. Her teaching experience, combined with hands-on laboratory expertise, makes her a well-rounded educator and researcher.

🔬 Research Focus:

Dr. Mekawy’s research primarily focuses on histopathological and immunohistochemical changes in response to environmental, chemical, and pharmaceutical exposures in animal models. Her investigations are centered on understanding tissue damage and repair mechanisms in organs like the liver, lungs, testes, heart, submandibular glands, and the central nervous system. A consistent theme across her work is evaluating the protective or therapeutic roles of natural substances and pharmacological agents, including antioxidants like Vitamin E, Nigella sativa, and Zingerone, as well as advanced treatments such as salivary exosomes and stem cells. She integrates light microscopy, electron microscopy, and molecular biology techniques in her research. Dr. Mekawy is also engaged in evaluating the histological effects of nanoparticles and energy drinks on various tissues. Her contributions are valuable for toxicological assessment and potential therapeutic innovations, contributing to public health and medical safety.

📚 Publications Top Notes:

  1. 🧪 Effect of Silver Nanoparticles on Testes of Prepubertal Male Albino Rats and the Possible Protective Role of Vitamin E

  2. ⚠️ Hepatic Changes under the Effect of Red Bull Energy Drinks and its Withdrawal in Adult Male Albino Rats

  3. 💧 Therapeutic Role of Salivary Exosomes in Improving Histological and Biochemical Changes Induced by Duct Ligation in Submandibular Glands

  4. ❤️ The Possible Protective Effect of Zingiber Officinale on Cyclophosphamide-Induced Cardiotoxicity

  5. 👁️ Protective Effect of Chrysin on Corneal Structural Alterations Induced by Sofosbuvir

  6. 🧬 Nicorandil and Bone Marrow-Derived Mesenchymal Stem Cells in Ureteric Obstruction Recovery

  7. 🧠 Effect of Zinc Oxide Nanoparticles on Cerebellar Cortex of Adult Male Albino Rats

  8. 🥼 Protective Role of Ghrelin versus its Combination with Zingerone on Gastric Ischemic-Reperfusion

  9. 🔊 Effect of Low Frequency Noise on Heart and Lung & Role of Vitamin C

  10. 💪 Nandrolone Effect on Cardiac Muscle and Role of Nigella Sativa

🧾 Conclusion:

Dr. Noura Mekawy exhibits the hallmarks of a dedicated, capable, and innovative researcher in medical science. With over a decade of academic and research experience, she has made valuable contributions to experimental histology and cell biology. Her work is methodologically sound, thematically diverse, and medically relevant. The strength of her research, consistent publication record, and academic integrity make her a highly suitable candidate for the Best Researcher Award. Continued growth in publication quality, global collaboration, and translational research will further enhance her already impressive academic journey.

Chen Huang | Cellular Bioenergetics Metabolism | Best Researcher Award

Published on by Cell Biologist

Dr. Chen Huang | Cellular Bioenergetics Metabolism | Best Researcher Award

Dr. Chen Huang , Shenzhen Institute of Advanced Technology (SIAT) Chinese Academy of Sciences (CAS) , China

Dr. Chen Huang is an Associate Researcher at the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences. She earned her Ph.D. in 2018 from the University of the Chinese Academy of Sciences. Her primary research lies at the intersection of female reproductive endocrinology and metabolic diseases, focusing on how adverse intrauterine environments impact long-term offspring health. Dr. Huang has authored over 20 SCI-indexed papers and holds 18 published patents with one under review. She has played significant roles in national and regional projects funded by the NSFC and Shenzhen Innovation Commission. Her notable contributions include identifying novel peptides with therapeutic potential in NAFLD and TNBC, and exploring molecular mechanisms behind pregnancy complications. Her impactful work, especially on metabolitin (MTL) and chemerin/GPR1 signaling pathways, has earned recognition in high-impact journals like Journal of Hepatology. Dr. Huang’s commitment to translational research places her at the forefront of biomedical innovation in women’s health.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Chen Huang exemplifies academic and scientific excellence through her impactful research in the fields of female reproductive endocrinology and metabolic diseases. Her contributions have led to meaningful advancements in understanding the molecular mechanisms that govern maternal-fetal health and associated disorders such as NAFLD, pregnancy complications, and cancer.

Key strengths include:

  • Scientific Innovation: She has identified and characterized novel peptide hormones such as metabolitin (MTL) and explored their therapeutic roles, a groundbreaking approach in targeting metabolic and oncological diseases.

  • High-Quality Publications: With around 20 SCI-indexed journal articles, including those in high-impact journals like Journal of Hepatology and Molecular Therapy – Oncolytics, her work is widely recognized in the scientific community.

  • Patent Portfolio: Dr. Huang has published 18 patents, with another under review, demonstrating her strong translational focus and commitment to real-world biomedical applications.

  • Research Leadership: She has successfully led multiple competitive national and regional research projects funded by the NSFC and Shenzhen Innovation Commission.

Areas for Improvement:

While Dr. Huang’s research output and contributions are impressive, certain enhancements could further elevate her global profile:

  • International Exposure: Engaging in more international collaborative projects or joint publications with global institutes could broaden the impact of her research.

  • Editorial and Professional Roles: Participation in editorial boards, peer review panels, or scientific committees would enhance her leadership presence in the scientific ecosystem.

  • Industry Engagement: Establishing collaborations with biotech or pharmaceutical industries could increase the translational value of her work and open pathways for clinical applications.

🎓 Education:

Dr. Chen Huang received her Ph.D. in 2018 from the University of the Chinese Academy of Sciences. Her doctoral research laid the foundation for her interest in female reproductive endocrinology and metabolic disorders, combining clinical insight with molecular research. Throughout her academic training, she focused on identifying the mechanistic links between endocrine disruptions during pregnancy and their long-term effects on offspring health. She has continually built upon this expertise through advanced training and interdisciplinary collaborations. Her educational background provided her with a robust understanding of molecular biology, endocrine physiology, and metabolic pathways, which she has applied in various research contexts—from liver disease to cancer biology. Her academic excellence was further highlighted by her early co-first authorship in high-impact journals during her Ph.D., demonstrating her ability to lead and innovate in collaborative research projects even in early stages of her career.

🧪 Experience:

Dr. Chen Huang is currently serving as an Associate Researcher at the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences. Since completing her Ph.D. in 2018, she has led and contributed to several key research projects, including those funded by the National Natural Science Foundation of China and the Shenzhen Science and Technology Innovation Commission. Her experience spans both basic and translational science, with an emphasis on hormonal regulation and metabolic diseases during pregnancy. She has collaborated with renowned scientists like Dr. Teng and Dr. Enkui Duan, contributing to the discovery of new peptide hormones such as metabolitin (MTL). Her professional experience is enriched by her ability to translate complex molecular findings into therapeutic strategies, especially in contexts like NAFLD and triple-negative breast cancer. With over 20 peer-reviewed SCI publications, her work reflects a consistent commitment to advancing biomedical research with clinical relevance.

🔬 Research Focus:

Dr. Chen Huang’s research focuses on the molecular underpinnings of female reproductive endocrinology and metabolic diseases, particularly within the context of pregnancy. She investigates how adverse intrauterine environments affect fetal development and contribute to long-term health issues in offspring. Her work explores key hormone-receptor interactions, such as the role of novel peptides (e.g., metabolitin) in liver disease and cancer. A major thread of her research also addresses the function of adipokines and their signaling pathways in pregnancy complications such as miscarriage and preeclampsia. Using both in vivo and in vitro models, she studies the regulatory mechanisms of trophoblast invasion, spiral artery remodeling, and immune cell interactions in the placenta. Her work integrates endocrinology, immunology, and developmental biology to identify new therapeutic targets. With an h-index of 12, she is recognized for her impactful publications and innovation in peptide-based treatments.

📚 Publications Top Notes:

  1. 🧬 Metabolitin (MTL) as a GPRC6A ligand improves NAFLD – Journal of Hepatology, 2020 (Co-first author)

  2. 🧪 Peptide blocks chemerin/GPR1 signaling to inhibit TNBC growth – Molecular Therapy – Oncolytics, 2020 (First author)

  3. 🔍 Adipokine promotes placental trophoblast invasion and vascular remodeling – Am J Physiol-Endocrinol Metab, 2019 (Co-first author)

  4. 🔬 mTOR hypoactivity causes trophectoderm failure via lysosomal activation – Cell and Bioscience, 2023

Conclusion:

Dr. Chen Huang is a highly deserving candidate for the Best Researcher Award. Her research contributions stand out in both innovation and societal impact, especially in the crucial domains of reproductive health and metabolic diseases. With a consistent publication record, numerous patents, and demonstrated research leadership, she is poised to make even greater scientific contributions in the years ahead. Recognizing her with this a

Fabian Fries | Gene Regulation Epigenetics | Young Scientist Award

Published on by Cell Biologist

Dr. Fabian Fries | Gene Regulation Epigenetics | Young Scientist Award

Dr. Fabian Fries , Universitätsklinikum des Saarlandes , Germany

Dr. Fabian N. Fries is a German ophthalmologist and senior consultant at Saarland University Medical Center. Born on July 18, 1990, in Germany, he has cultivated a career marked by clinical excellence, research productivity, and international experience. Following his medical studies at Saarland University, he gained practical experience across the U.S., Brazil, and Germany. Dr. Fries has authored over 15 peer-reviewed publications and earned an H-index of 16, reflecting his impactful contributions in ophthalmology. A polyglot and DAAD scholar, he is also actively engaged in professional societies like the German Ophthalmological Society. His research interests include corneal diseases, ocular surface disorders, and regenerative therapies involving limbal stem cells. Apart from his medical pursuits, he’s a competitive athlete, excelling in tennis and athletics. Dr. Fries combines clinical competence, research acumen, and a collaborative mindset, positioning him as an outstanding candidate for early-career research recognition.

Publication Profile:

Orcid

✅ Strengths:

  1. 📈 Strong Research Metrics

    • H-index: 16, i10-index: 22, and 742 citations—solid indicators of impactful and consistent academic output.

    • Authored 15 peer-reviewed publications in high-impact journals like The Ocular Surface, Experimental Eye Research, and International Journal of Molecular Sciences.

  2. 🧬 Innovative Research Focus

    • His work bridges molecular biology and clinical ophthalmology, especially in limbal stem cell deficiency, PAX6 gene regulation, miRNA expression, and corneal diseases.

    • Focus on translational science with direct implications for therapy and regenerative medicine.

  3. 🌍 International Exposure

    • Completed clinical internships in USA, Brazil, and Germany, showcasing adaptability, cultural competence, and international collaboration.

  4. 💼 Professional Leadership

    • Currently a Senior Consultant at Saarland University Medical Center.

    • Certified teaching assistant, actively mentoring young medical professionals.

  5. 🏅 Recognized Excellence & Extracurriculars

    • Multiple scholarships: DAAD, e-fellows.net, and Saarland University.

    • Athlete-scholar with national-level performance in tennis and athletics, highlighting discipline, commitment, and well-rounded personality.

  6. 🧠 Tech-Savvy & Multilingual

    • Proficient in SPSS, Java, SAP ERP, and fluent in 6 languages, positioning him uniquely for cross-disciplinary, global projects.

📉 Areas for Improvement:

  1. 🌐 Global Research Fellowships or Visiting Scientist Roles

    • While he has international clinical experience, postdoctoral research fellowships abroad (e.g., US, UK, or Japan) could further enrich his research perspective and expand collaborations.

  2. 📣 Greater Visibility as a Lead Investigator

    • Most of his studies are in collaboration with senior figures. More first-author or corresponding-author publications, and leading independent research grants, would bolster his profile.

  3. 🎤 Science Communication/Public Engagement

    • Active roles in public engagement, conferences, or science communication platforms would amplify his influence and visibility outside academic circles.

🎓 Education:

Dr. Fries completed his Abitur in Saarland, Germany in 2009 and subsequently pursued medicine at Saarland University, completing his state medical examination in 2016. His medical education was enriched by several international internships: Children’s of Alabama (USA), Instituto de Neurologia de Curitiba (Brazil), and various institutions in Germany. These experiences provided him with a strong foundation in global healthcare environments and interdisciplinary approaches to medical problems. His training emphasized ophthalmology, medical technology, and corneal research. In addition to his clinical education, he developed proficiency in research methodologies, statistical software (SPSS), and even programming in Java—an uncommon strength among clinicians. His multilingualism (German, English, French, Spanish, Portuguese, Latin) further reflects a well-rounded academic and professional profile. He has also received scholarships from the DAAD, Saarland University, and e-fellows.net. This robust educational background is a solid base for his continued clinical and academic excellence in ophthalmology.

💼 Professional Experience:

Dr. Fries is currently a Senior Consultant in Ophthalmology at Saarland University Medical Center (since 2021), where he also completed his residency (2016–2021). He brings over a decade of experience in clinical practice, teaching, and research. His clinical roles have spanned multiple specialties and continents, including stints at Children’s of Alabama, the Instituto de Neurologia de Curitiba, and top institutions in Germany. He has participated in pioneering electronic health record integration projects and led efforts in corneal transplant innovations. His experience also includes medical internships in both hospitals and private practices, providing a broad spectrum of exposure from surgical practice to patient-centered outpatient care. Additionally, he is a certified teaching assistant at Saarland University and has been actively involved in the supervision of junior residents and students. His commitment to high-standard care and continuous education is evident in his leadership roles and collaborative projects.

🏆 Awards and Honors:

Dr. Fries has received several academic and research accolades that highlight his potential as a leading young scientist. He was awarded scholarships from the prestigious DAAD (German Academic Exchange Service), Saarland University, and e-fellows.net, reflecting academic excellence and leadership. His athletic achievements include participation in the German University Tennis Championships (2015, 2016), where he won multiple regional titles and achieved a 5th place ranking in the German Team Athletics Championships (2014). In research, his contributions are recognized through a strong H-index of 16, 742 citations, and an i10-index of 22, underlining consistent and impactful scientific productivity. He is a member of key academic societies, including the German Ophthalmological Society, Professional Association of Ophthalmologists, and others since 2016. His well-rounded excellence in science, teaching, international exposure, and sports makes him an exceptional candidate for the Research for Young Scientist Award.

🔬 Research Focus:

Dr. Fabian Fries focuses his research on ocular surface diseases, particularly limbal stem cell deficiency, corneal dystrophies, and regenerative approaches in ophthalmology. His work dives deep into molecular mechanisms, such as PAX6 signaling, microRNA pathways, and retinoic acid signaling, all pivotal in corneal health and disease. Using advanced cell culture models and patient tissue analysis, his research offers insights into pathophysiological processes affecting corneal epithelial integrity. Additionally, he explores the impact of genetic mutations and inflammatory mediators on disease progression. Dr. Fries has contributed significantly to translational research, bringing lab discoveries into clinical settings, notably in corneal transplantation and novel therapeutic strategies. He also examines digital integration in ophthalmology via projects like FIDUS EHR implementation. His interdisciplinary, collaborative, and bench-to-bedside approach places him at the forefront of young clinician-scientists driving innovation in ophthalmology.

📚 Publications Top Notes:

  1. 🧬 Effect of MiRNA 204-5P Mimics and LPS on Retinoic Acid Signaling in Limbal Epithelial Cells

  2. 🔬 Decreased PAX6 and DSG1 in Corneal Epithelium of EBMD, SND, and Pterygium Patients

  3. 🧫 FABP5 and DSG1 Downregulation after PAX6 Knockdown in Limbal Cells

  4. 💻 Employee Survey Post-FIDUS EHR Introduction at Saarland Eye Hospital

  5. 👁 Endothelial Cell Density and Corneal Thickness Post-Keratoplasty for Acanthamoeba Keratitis

  6. 🩸 Intravenous Fibrinolysis for Nonarteritic Central Retinal Artery Occlusion – Feasibility Study

  7. ⚠️ Pronounced Band Keratopathy in Refsum’s Syndrome – Case Report

  8. 🔎 Unilateral Macular Pigment Epitheliitis in a 38-Year-Old – Diagnostic Insights

  9. 🧬 MicroRNA and Gene Expression Changes in Limbal Deficiency Modulated by PAX6 Mutation

  10. 🧠 Acute Visual Loss from Basilar Artery Aneurysm-induced Subarachnoid Hemorrhage

🏁 Conclusion:

Dr. Fabian N. Fries stands out as a highly qualified, ambitious, and impactful early-career scientist whose research bridges the gap between basic science and clinical innovation in ophthalmology. His contributions to ocular surface research, particularly in the context of limbal stem cells and gene regulation, are of significant academic and therapeutic value. He brings a unique mix of clinical excellence, internationalism, technological proficiency, and scientific curiosity.

WEI HUANG | Mitochondrial Function Dynamics | Best Researcher Award

Published on by Cell Biologist

Dr. WEI HUANG | Mitochondrial Function Dynamics | Best Researcher Award

Dr. WEI HUANG , Aier Glaucoma Institute, Hunan Engineering Research Center for Glaucoma with Artificial Intelligence in Diagnosis and Application of New Materials, Changsha Aier Eye Hospital , China

Dr. Wei Huang is a highly skilled ophthalmologist with a robust background in clinical and experimental ophthalmology. She earned her Bachelor’s in Clinical Medicine from Shanxi Medical University (2010-2013), followed by a Master’s and Ph.D. in Ophthalmology from Xiangya Medical School, Central South University (2013-2021). Dr. Huang has made significant contributions to dry eye disease, stem cell therapy, and ocular pharmacology. She currently works as an ophthalmologist at Changsha Aier Eye Hospital, continuing her research on dry eye inflammation and novel therapeutic agents. With extensive experience in clinical trials, pre-clinical drug development, and molecular biology, she has been a key researcher in various cutting-edge studies. Her dedication to advancing ophthalmic treatments is evident in her numerous publications, many of which focus on innovative drug delivery systems and stem cell applications in eye diseases. Dr. Huang’s expertise has earned her recognition in both China and the U.S. for her scientific contributions.

Publication Profile:

Orcid

Strengths for the Award:

  1. Extensive Academic Background:

    • Huang Wei has an impressive academic background in Clinical Medicine and Ophthalmology, holding a Ph.D. from Central South University, as well as significant post-graduate experience in clinical settings. She has gained comprehensive expertise through various prestigious institutions, including work as a Senior Research Support Specialist at the State University of New York and as an ophthalmologist at Sun Yat-sen Memorial Hospital and Changsha Aier Eye Hospital.

  2. Exceptional Research Experience:

    • Huang’s research contributions, particularly in ophthalmology, dry eye disease, stem cells, and drug development, have led to numerous publications in high-impact journals like the Journal of Ocular Pharmacology and Therapeutics and Experimental Eye Research. She has been the lead researcher and coordinator on multiple successful projects and clinical trials, particularly focused on innovative drug therapies and experimental models.

  3. Pioneering Drug Development and Stem Cell Research:

    • Her research involving human umbilical cord blood-derived mesenchymal stem cells for regenerative medicine and her clinical trial work with novel NSAID formulations for dry eye disease showcases her pioneering role in advancing both pre-clinical and clinical drug development.

  4. Expert in Ophthalmological Techniques:

    • Huang demonstrates proficiency in a wide range of advanced experimental and clinical techniques, including ocular microsurgery, advanced imaging, animal modeling, and molecular biology. Her expertise in both basic science and clinical research equips her to bridge the gap between laboratory findings and clinical applications, which is an essential aspect of impactful medical research.

  5. Leadership and Recognition:

    • She has earned full scholarships for both her M.S. and Ph.D., demonstrating strong academic excellence. Additionally, her publication record is robust, with over 16 peer-reviewed journal articles and several key contributions to research projects focused on eye disease mechanisms and therapies.

  6. Global Recognition:

    • Her collaborative work across international institutions, coupled with her ability to bring together multiple research teams and fields, places her at the forefront of ophthalmic and medical research. Her work is highly regarded, and she holds substantial influence in the field of dry eye disease research.

Areas for Improvement:

  1. Broader Public Engagement and Outreach:

    • While Huang’s contributions to peer-reviewed journals and clinical settings are undeniable, expanding her involvement in public outreach, particularly to raise awareness about new treatments in ophthalmology or stem cell research, could increase her visibility and engagement within the broader medical and patient communities.

  2. Diverse Collaborative Networks:

    • Huang has primarily worked within the realm of ophthalmology and stem cell research. Exploring cross-disciplinary collaborations outside of ophthalmology, such as in molecular genetics, biomedical engineering, or artificial intelligence for drug development, could further diversify her research impact and innovation.

  3. Leadership in Research Strategy and Funding:

    • Although she has demonstrated strong leadership in individual research projects, Huang could work toward taking on more leadership roles in strategic planning, grant applications, and the overall direction of large-scale research initiatives. This would solidify her role not only as a researcher but as a leader in the field of medical research.

Education:

Dr. Wei Huang began her academic journey at Shanxi Medical University, where she completed her Bachelor of Science in Clinical Medicine between 2010 and 2013. She then pursued her M.S. and Ph.D. in Ophthalmology at Xiangya Medical School, Central South University, one of the top medical institutions in China. During her Ph.D. studies (2013-2021), Dr. Huang focused on ocular pharmacology and stem cell therapies, particularly in the context of retinal diseases and dry eye syndrome. Her research has been supported by various prestigious grants, including the National Natural Science Foundation of China, underscoring her academic excellence. Throughout her education, she received full scholarships for her Master’s and Ph.D. programs. Her educational journey reflects a strong commitment to ophthalmology, evidenced by her continuous pursuit of both theoretical knowledge and practical experience in the field of eye care and treatment development.

Experience:

Dr. Wei Huang has gained extensive experience in both research and clinical ophthalmology. She worked as a Senior Research Support Specialist at the Medicine Department of the State University of New York from 2017 to 2020, focusing on ocular disease models and pre-clinical drug development. In 2021, she transitioned to clinical practice as an Ophthalmologist and Post-Ph.D. researcher at Sun Yat-sen Memorial Hospital, Sun Yat-sen University, where she led studies on ocular inflammation and dry eye disease. In 2023, she joined Changsha Aier Eye Hospital, continuing her clinical practice while conducting cutting-edge research on ocular inflammation and therapeutic interventions. Dr. Huang’s research skills span ocular microsurgery, clinical trials, and molecular biology, making her a leader in ophthalmological innovations. Throughout her career, she has made significant contributions to the treatment of dry eye disease, retinal degeneration, and optic neuropathy, with a focus on drug development and stem cell therapies.

Awards and Honors:

Dr. Wei Huang has received numerous prestigious awards for her academic and professional achievements. She was honored with a Ph.D. Full Scholarship from Central South University (2016-2019) and an M.S. Full Scholarship (2013-2016), recognizing her exceptional academic potential and research contributions. Additionally, she received the B-level Scholarship from Shanxi Medical University (2008-2013) during her undergraduate studies. Her academic excellence has led to her selection for various research projects funded by the National Natural Science Foundation of China. She has also earned a Professional Medical License, validating her clinical expertise. Dr. Huang’s dedication to research has been recognized internationally, with multiple publications in high-impact journals, further solidifying her reputation in the ophthalmology community. As a certified Good Clinical Practice (GCP) professional in both China and the U.S., she continues to contribute to advancing ophthalmic therapies through rigorous clinical trials and innovative treatments.

Research Focus:

Dr. Wei Huang’s research primarily focuses on ophthalmology, with a particular emphasis on dry eye disease, stem cell therapy, and the development of novel pharmacological treatments for ocular conditions. Her work includes exploring the use of mesenchymal stem cells from human umbilical cord blood in treating retinal ganglion cells and optic nerve regeneration, a project funded by the National Natural Science Foundation of China. She also leads research in pre-clinical drug development for dry eye syndrome, investigating the effectiveness of phospho-modified NSAIDs in treating ocular inflammation. Dr. Huang is deeply involved in clinical trials, including those exploring the safety and efficacy of novel treatments for primary open-angle glaucoma and traumatic optic neuropathy. She is currently investigating the mechanisms behind Sjögren’s syndrome-associated dry eye inflammation and the potential for mitochondrial fatty acid oxidation to inhibit this inflammation. Dr. Huang’s research aims to transform the therapeutic landscape of various ocular diseases, improving patient outcomes.

Publications Top Notes:

  1. Hydrogel formulation of phosphosulindac allows once-a-day ocular dosing and limits its biodistribution to the anterior chamber: Application to dry eye disease treatment 🧴👁️

  2. Traditional two-dimensional mesenchymal stem cells (MSCs) are better than spheroid MSCs on promoting retinal ganglion cells survival and axon regeneration 🧬👀

  3. Once-Daily Topical Phosphosulindac Is Efficacious in the Treatment of Dry Eye Disease: Studies in Rabbit Models 🐇💧

  4. Phospho-Sulindac (OXT-328) Inhibits Dry Eye Disease in Rabbits: A Dose-, Formulation- and Structure-Dependent Effect 🧪🧴

  5. Animal models of dry eye disease: Useful, varied and evolving (Review) 📚🔬

  6. Simplified ex-vivo drug evaluation in ocular surface cells: Culture on cellulose filters of cells obtained by impression cytology 🔬🧫

  7. The transcriptome of rabbit conjunctiva in dry eye disease: Large-scale changes and similarity to the human dry eye 🧬👁️

  8. Establishment of a Severe Dry Eye Model Using Complete Dacryoadenectomy in Rabbits 🐰🔬

  9. NSAID-induced corneal melt: Clinical importance, pathogenesis, and risk mitigation 💉🧑‍⚕️

Conclusion:

Dr. Huang Wei is a highly qualified and accomplished researcher with outstanding contributions to the field of ophthalmology, particularly in the development of new treatments for dry eye disease and regenerative medicine. Her extensive research experience, coupled with her leadership roles in clinical trials and drug development, makes her an ideal candidate for the Best Researcher Award.

Dmytro Maltsev | Gene Regulation Epigenetics | Best Review Paper Award

Published on by Cell Biologist

Mr. Dmytro Maltsev | Gene Regulation Epigenetics | Best Review Paper Award

Mr. Dmytro Maltsev , O’Bogomolets National Medical University , Ukraine

Dr. Dmytro Maltsev is a Ukrainian neuroimmunologist, physician-scientist, and clinical researcher with a PhD in medicine. He serves as the head of the Laboratory of Immunology and Molecular Biology at the Research Institute of Experimental and Clinical Medicine, O’Bogomolets National Medical University, Kyiv. His extensive body of work spans neuroimmunology, autoimmune encephalitis, herpesvirus infections, and immune deficiencies. He is the author of 29 books and over 340 scientific papers, with 50 indexed in Scopus. His work has earned several prestigious awards, including recognition from the National Academy of Sciences of Ukraine and international congresses. He actively collaborates with institutions like the Mayo Clinic (USA) and the Institute of Neurosurgery (Ukraine). Dr. Maltsev is a member of multiple professional societies, including the European Academy of Neurology. His groundbreaking GBINS protocol for autistic spectrum disorder highlights his contributions to precision medicine and multidisciplinary approaches in neuropsychiatric care.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Pioneering Work:
    Dr. Maltsev’s systematic review on herpesviral encephalitis presents a groundbreaking clinic-radiological classification, offering a unifying framework that enhances clinical diagnostics and therapeutic planning.

  2. Depth and Breadth of Expertise:
    The review showcases deep neuroimmunological insight, drawing from over 340 publications, including 50 in SCOPUS, and extensive experience in both clinical and laboratory settings.

  3. Interdisciplinary Integration:
    He combines advanced techniques—PCR, ELISA, western blot, flow cytometry—with clinical observations, resulting in practical classifications and diagnostic pathways.

  4. Relevance and Timeliness:
    The review addresses a critical gap in understanding viral encephalitides, which are often misdiagnosed or under-reported, contributing to early interventions and improved patient outcomes.

  5. International Collaboration:
    Collaborative ties with the Mayo Clinic (USA) and leading Ukrainian research institutions add credibility and global relevance to his work.

  6. Proven Impact:
    Recognized for prior scientific excellence through national and international awards, including recognition from the National Academy of Sciences of Ukraine and the World Congress of Immunopathology.

🧭 Areas for Improvement:

  1. Editorial Involvement:
    Currently, Dr. Maltsev does not hold editorial roles, which could enhance his influence in shaping the field’s publication standards and peer-review frameworks.

  2. Digital Science Communication:
    Expanding public engagement via open-access formats, social media science explainers, or video summaries would amplify the reach of his reviews beyond academia.

  3. Visual Data Representation:
    While the review is methodically comprehensive, adding infographics, visual summaries, or interactive diagnostic flowcharts could enhance reader accessibility, particularly for multidisciplinary teams.

🎓 Education:

Dr. Dmytro Maltsev pursued his medical education and PhD at O’Bogomolets National Medical University in Kyiv, Ukraine. Early in his academic career, he displayed an interest in immunopathology and clinical biology. His PhD focused on the clinical and immunological aspects of herpesvirus infections and their role in neuroinflammatory diseases. His educational path included specialization in molecular biology techniques such as PCR, ELISA, immunofluorescence, and flow cytometry. His training also incorporated translational research and clinical diagnostics, equipping him with a multidisciplinary approach essential for modern neuroimmunology. With further professional development in clinical immunology and collaboration with international research groups, including the Mayo Clinic, Dr. Maltsev has refined his knowledge in personalized medicine. He actively mentors postgraduate students, and his research findings are frequently integrated into educational materials, including textbooks and monographs used in university-level instruction throughout Ukraine and abroad.

💼 Professional Experience:

Dr. Dmytro Maltsev has over 20 years of professional experience in neuroimmunology and molecular medicine. As the head of the Laboratory of Immunology and Molecular Biology at O’Bogomolets National Medical University, he leads research on immune system dysfunction, neurodevelopmental disorders, and viral neuropathology. His professional journey includes clinical consultancy, authorship of 29 medical books, and over 340 published studies. He has completed 8 major research projects and collaborated on 4 industry-funded studies. Dr. Maltsev also holds 16 patents and actively participates in international scientific communities. His work spans diagnostics, therapy innovation, and personalized medicine, including the creation of GBINS, a treatment framework for children with autism spectrum disorders. Recognized for pioneering work on minor immunodeficiencies and viral encephalitis classifications, he has received multiple national and international awards. Dr. Maltsev collaborates globally with neurologists and immunologists, contributing to consensus guidelines, systematic reviews, and cross-continental case studies.

🔬 Research Focus:

Dr. Maltsev’s research focuses on neuroimmunology, specifically immune-related neurological and psychiatric disorders. He investigates immunodeficiency syndromes, herpesvirus-induced encephalitis, autoimmune epilepsies, and autism spectrum disorders (ASD) associated with folate cycle genetic deficiencies. His work emphasizes personalized, multidisciplinary treatments through laboratory diagnostics like PCR, ELISA, immunoblotting, immunofluorescence, and flow cytometry. A core achievement is the GBINS protocol, offering a targeted therapy model for children with ASD. He also researches immunoglobulin E deficiency and alpha/beta-defensin involvement in oral cancer complications. His aim is to bridge immune dysfunction with neurological pathologies, improving diagnostic accuracy and patient outcomes. By classifying new immune-related diseases and pioneering treatment options, Dr. Maltsev contributes significantly to immunotherapy and neurorehabilitation. He also explores how AI can enhance diagnosis and therapy across various disciplines. His dedication to translational research supports the development of individualized care protocols, with ongoing global collaborations in Europe, the USA, and beyond.

📚 Publication Top Notes:

  1. 🧠 Clinic-radiological classification of herpesviral encephalitis in humans (Systematic review)

  2. 🧬 Integrative concept of pathogenesis and GBINS personalized multidisciplinary approach to ASD in children

  3. 💉 Risk factors for grade III radiation-induced mucositis in oral/oropharyngeal cancer therapy

  4. 🧫 Microbial infections in children with ASD and genetic folate cycle deficiency

  5. 🧪 Primary minor immunodeficiencies as a cause of immune-dependent pathology (Systematic review)

  6. 🌍 Global presence and penetrance of CSF1-related disorder

  7. 💊 Treatment of reactivated EBV, HHV-6, HHV-7 in children with ASD and folate cycle disruption

  8. 🤖 Trends in the use of AI in diagnosis and treatment

  9. 🛡️ Alpha/beta-defensins’ influence on immunity in oral/oropharyngeal cancer

  10. 🌐 Global presence of CSF1R-Related disorder: A multinational case series

🏁 Conclusion:

Dr. Dmytro Maltsev is highly deserving of the Best Review Paper Award for his exemplary scholarly contribution titled:
“Clinic-radiological classification of herpesviral encephalitis in humans (Systematic Review)”, published in the Journal of NeuroVirology (2025).

His work offers clinical utility, theoretical innovation, and a robust, evidence-based approach to a complex neuroinfectious condition. With continued emphasis on global engagement and editorial leadership, Dr. Maltsev is poised to remain a key thought leader in neuroimmunology.

SANKALP MISRA | Microbiology | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. SANKALP MISRA | Microbiology | Best Researcher Award

Assist. Prof. Dr. SANKALP MISRA , Shri Ramswaroop Memorial University , India

Dr. Sankalp Misra is a dedicated microbiologist with a Ph.D. in Microbial Technology, currently working as a Research Associate at CSIR-National Botanical Research Institute (NBRI), Lucknow. Born on November 6, 1988, in India, he has cultivated a robust academic and research career focused on plant-microbe interactions and sustainable agriculture. Fluent in both English and Hindi, Dr. Misra has consistently demonstrated a commitment to addressing real-world agricultural challenges through microbiological innovations. His research explores the symbiotic relationships between soil microbes and plants, particularly under stress conditions such as salinity and drought. With a host of fellowships, awards, and scientific publications to his name, Dr. Misra is not only a prolific researcher but also a valued contributor to India’s agricultural biotechnology community. He is a life member of the Association of Microbiologists of India and continues to contribute actively to scientific dialogue and applied research in microbial ecology.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Extensive Research Experience
    Over 10 years of continuous research in microbial biotechnology, especially plant-microbe interactions, bioremediation, and stress physiology, primarily under the CSIR-NBRI—a top-tier research institution in India.

  2. Focused Scientific Contributions
    His Ph.D. work on salt-tolerant plant growth-promoting rhizobacteria (PGPR) addresses crucial agricultural challenges, with implications in sustainable farming and climate-resilient agriculture.

  3. Prolific Publication Record
    Co-authored over 15 research papers and book chapters in high-impact journals and internationally reputed publishers (Springer, Wiley, Academic Press).

  4. Nationally Recognized Fellowships & Awards

    • ICMR Research Associate & Senior Research Fellowship

    • Gold Medalist in B.Sc.

    • Multiple Best Poster Awards in national and international conferences

    • Consistent CSIR-UGC NET success (31st and 47th ranks)

  5. Professional Engagement
    Holds a Life Membership in The Association of Microbiologists of India, reflecting his active involvement in the scientific community.

  6. Interdisciplinary Expertise
    Skilled in proteomics, metagenomics, microbial ecology, and plant stress biology, showcasing an ability to tackle complex problems from multiple biological angles.

⚙️ Areas for Improvement:

  1. International Exposure
    While the research is nationally strong, global collaborations or international fellowships could further elevate the impact and visibility of his work.

  2. Grant Leadership & Independent Projects
    Leading funded projects as a Principal Investigator (PI) would demonstrate further maturity in research leadership and scientific management.

  3. Patent/Technology Transfer
    Translating research into patents, bio-formulations, or industry partnerships could bridge the lab-to-land gap, enhancing the practical application of his findings.

🎓 Education:

Dr. Sankalp Misra completed his Ph.D. in Microbial Technology from CSIR-NBRI, focusing on the “Characterization of salt tolerant plant growth promoting rhizobacteria from different agro-climatic zones of Uttar Pradesh.” Guided by Dr. Puneet Singh Chauhan, his doctoral work laid a foundation in microbial stress biology. He qualified the prestigious CSIR-UGC NET in both 2013 (47th rank) and 2014 (31st rank), showcasing strong academic competence. He also cleared the CET-Ph.D in 2012. His undergraduate studies were marked by excellence, earning a Gold Medal in B.Sc., emphasizing his early commitment to academic rigor. These achievements underline his solid foundation in microbiology, plant biology, and biotechnological research. Throughout his educational journey, Dr. Misra has consistently demonstrated a deep curiosity for microbial applications in agriculture and an aptitude for integrating advanced scientific methods to address pressing challenges in crop sustainability and soil health.

💼 Experience:

Dr. Sankalp Misra has over a decade of research experience in plant-microbe interactions. He is currently an ICMR-Research Associate at CSIR-NBRI since October 2019. Prior roles include ICMR-Senior Research Fellow and several project fellowships at CSIR-NBRI from 2013 to 2019. These positions allowed him to work on key projects involving soil microbiomes, salt and drought stress in plants, and bioremediation. His extensive hands-on experience ranges from lab-based experiments to field applications, focusing on sustainable and ecological approaches in agriculture. He has significantly contributed to the development of microbial formulations and transgenic studies aimed at improving crop resilience. His continuous association with CSIR-NBRI reflects a stable and productive research career. Each role has helped him refine his techniques in molecular biology, microbiome analysis, and biotechnological innovation, making him a competent and valuable researcher in environmental microbiology and sustainable agricultural practices.

🏅 Awards and Honors:

Dr. Misra has received multiple accolades recognizing his scientific excellence. He was awarded the prestigious ICMR Research Associateship (Oct 2019) and Senior Research Fellowship (July 2019), reflecting national-level recognition. His scientific presentations have earned him Best Poster Awards in major conferences, including the 3rd National Seminar on Life Sciences (NSCTLS-2021) and the 6th International Conference on Plants and Environmental Pollution (ICPEP-6, 2018). Academically, he secured top ranks in CSIR-UGC NET (31st in 2014 and 47th in 2013) and earned a Gold Medal in B.Sc., demonstrating exceptional merit throughout his academic and research career. His commitment is further underscored by his life membership in The Association of Microbiologists of India (AMI). These achievements highlight his consistent dedication, peer recognition, and leadership potential in the fields of microbiology and agricultural biotechnology.

🔍 Research Focus:

Dr. Sankalp Misra’s research centers on plant-microbe interactions, especially under environmental stress like salinity and drought. He explores rhizobacteria that promote plant growth and mitigate stress through mechanisms such as ACC deaminase production, metabolomic reprogramming, and soil microbial community enhancement. His interests extend to soil metagenomics, microbial proteomics, and bioremediation, all aimed at achieving sustainable agriculture. A key aspect of his work involves isolating and characterizing stress-tolerant microbes from diverse agro-climatic zones, using them to enhance crop resilience and productivity. His work contributes to global efforts in climate-resilient farming, making him a notable figure in applied agricultural microbiology. He has co-authored numerous high-impact publications and book chapters that explore these themes, confirming his deep engagement in cutting-edge microbial biotechnology.

📚 Publications Top Notes:

  1. 🌱 Enhancement of Drought Tolerance in Transgenic Arabidopsis thaliana Plants Overexpressing Chickpea Ca14-3-3 Gene

  2. 🦠 Novel trends in endophytic applications for plant disease management

  3. 🌍 Rhizobacteria‐Mediated Bioremediation: Insights and Future Perspectives

  4. 🌾 Endospheric Microbiome-Assisted Alteration in the Metabolomic Profiling of Host towards Abiotic Stress Mitigation

  5. 🧬 Revealing the complexity of protein abundance in chickpea root under drought-stress using comparative proteomics

  6. 🔬 Characterization of alkalotolerant Alcaligenes and Bacillus strains for mitigating alkaline stress in Zea mays

  7. 🌿 Drought tolerant Ochrobactrum sp. inoculation helps maintain homeostasis in Zea mays under water stress

  8. ⚗️ ACC deaminase-producing Bacillus spp. mitigate salt stress and enhance Zea mays growth

  9. 🧪 Exploration of Soil Resistome Through a Metagenomic Approach

  10. 🍃 Essential Oils: Potential Application in Disease Management

📝 Conclusion:

Dr. Sankalp Misra is an excellent and deserving candidate for the Best Researcher Award. His consistent contributions to microbial biotechnology, evidenced by a strong portfolio of peer-reviewed publications, government fellowships, and research impact, make him stand out in his field. His work is not only academically significant but also socially and environmentally relevant in addressing global issues like soil degradation, crop yield loss due to climate stress, and sustainable agriculture.

Allegra Wundersitz | Signal Transduction Mechanisms | Young Scientist Award

Published on by Cell Biologist

Mrs. Allegra Wundersitz | Signal Transduction Mechanisms | Young Scientist Award

Mrs. Allegra Wundersitz , RWTH Aachen University, Molekulare Ökologie der Rhizosphäre , Germany

Allegra Wundersitz is a passionate molecular biologist currently pursuing her PhD at RWTH Aachen University, Germany, in the group of Molecular Ecology of the Rhizosphere. Her research delves into the molecular mechanisms of plant oxygen sensing and the regulatory role of acyl-CoA-binding proteins (ACBPs) in stress signaling. Allegra has been recognized for her academic excellence, receiving the ISPA Poster Award and the Best Botanic Master’s Thesis Award from the German Society for Plant Sciences (DBG). With expertise in cloning, yeast-two-hybrid, luciferase complementation, and computational modeling, she seamlessly integrates biochemical and molecular approaches. Allegra actively collaborates with interdisciplinary teams, bridging plant physiology, structural biology, and molecular dynamics. Her commitment to research and mentoring makes her a promising young scientist aiming to contribute not only to fundamental plant science but also to translational applications in health and agriculture.

Publication Profile:

Orcid

✅ Strengths for the Award:

  • Innovative Research Focus: Allegra’s work on acyl-CoA-binding proteins (ACBPs) in plant oxygen sensing and stress signaling demonstrates high originality. Her approach of integrating protein biochemistry, gene regulation, and computational modeling is both novel and impactful.

  • Early Recognition: Despite being in the early stages of her career, she has received notable honors, including the ISPA Poster Award and the Best Master’s Thesis Award (DBG)—highlighting the quality and relevance of her work.

  • Interdisciplinary Collaboration: She engages with experts in molecular dynamics and structural biology, enriching her research with advanced modeling of protein mutations—showing strong collaborative and technical competencies.

  • Mentorship & Leadership: Supervising undergraduate students showcases her commitment to academic development and science communication.

  • Publication Record: Her first peer-reviewed article in New Phytologist indicates strong potential for growing her scientific influence.

🧩 Areas for Improvement:

  • Professional Engagement: Joining relevant scientific societies or organizations could enhance her visibility, offer networking opportunities, and provide access to grants or awards.

  • Industry Exposure: While her current focus is on basic science, even limited engagement with applied research or biotechnology partnerships could broaden the translational scope of her work.

  • Publication Volume: As her research matures, expanding her publication record beyond reviews into primary experimental studies will strengthen her academic profile.

🎓 Education:

Allegra Wundersitz holds a Master’s degree in Plant Molecular Biology, where her thesis on acyl-CoA-binding proteins (ACBPs) earned national recognition by the German Society for Plant Sciences in 2024. She is currently a PhD student at RWTH Aachen University, Germany, specializing in the molecular ecology of the rhizosphere. Her academic training spans core fields such as structural biochemistry, plant physiology, and gene regulation. Through hands-on learning and international workshops, she has developed technical proficiency in protein interaction assays, biosensor design, and in silico modeling. Her education emphasizes a multidisciplinary approach, blending experimental and computational biology. She has also supervised undergraduate research projects, further strengthening her academic leadership. Allegra’s educational journey reflects her deep curiosity for understanding molecular mechanisms in plant biology and their broader implications.

🧪 Experience:

Allegra’s experience is rooted in academic molecular biology research. During her Master’s and now as a PhD candidate, she has completed two significant research projects: developing plant-based oxygen biosensors and exploring the role of ACBPs in gene regulation. Her current PhD project investigates how ACBPs act as acyl-CoA receptors, mediating responses to oxygen and stress in plants. She employs techniques such as yeast two-hybrid assays, luciferase complementation, cloning, and molecular modeling. Allegra has also collaborated with experts in molecular dynamics, including Prof. Maria Fyta and Dr. Chandan Das, to simulate structural effects of ACBP mutations. She has presented her work at international conferences and received a prestigious poster award at ISPA. Allegra is gaining valuable teaching experience through undergraduate supervision, making her a well-rounded early-career scientist. Though she has not yet worked in industry, her work holds potential translational value in agriculture and health.

🔍 Research Focus:

Allegra’s research centers on the role of acyl-CoA-binding proteins (ACBPs) as key molecular players in plant oxygen sensing and stress signaling. She investigates how ACBPs function as acyl-CoA receptors and modulate gene expression through dynamic protein-protein interactions. Her goal is to uncover how lipid signals like acyl-CoAs are translated into physiological responses under stress conditions. Using a combination of experimental techniques—such as cloning, luciferase complementation assays, yeast-two-hybrid screens—and computational molecular dynamics, she deciphers the structural and functional aspects of ACBP interactions. Her research not only expands fundamental plant molecular biology but also contributes insights with potential applications in crop resilience, metabolic regulation, and even human health, given ACBPs’ links to cancer and metabolic disorders. Through interdisciplinary collaboration, Allegra aims to bridge structural biochemistry and plant physiology to understand how cells adapt to fluctuating oxygen and energy levels.

📚 Publications Top Notes:

  • 🧬 Acyl-CoA-binding proteins: bridging long-chain acyl-CoA metabolism to gene regulation – Tansley Insight, New Phytologist (April 22, 2025)

🧾 Conclusion:

Allegra Wundersitz is a highly promising young researcher who combines technical excellence, creativity, and interdisciplinary integration in her approach to plant molecular biology. Her foundational work on ACBPs not only deepens our understanding of plant stress responses but also hints at broader implications in health and metabolic research. With her trajectory and dedication, she is an ideal candidate for the Young Scientist Award, and this recognition would further support her impactful scientific journey.

Wageha AWad | Host-Pathogen Interactions | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Wageha AWad | Host-Pathogen Interactions | Best Researcher Award

Assist. Prof. Dr. Wageha AWad , University of Veterinary Medicine , Austria

Ass. Prof. Dr. Wageha Awad is a renowned Austrian scientist specializing in poultry and intestinal physiology. Based at the University of Veterinary Medicine, Vienna, she brings decades of hands-on experience in veterinary sciences, with a sharp focus on poultry gut health, host-pathogen interactions, and mycotoxin research. Her academic journey spans multiple prestigious institutions across Europe, including postdoctoral work at the Free University of Berlin under the Alexander von Humboldt Foundation. Dr. Awad’s prolific career includes numerous publications in high-impact journals and memberships in key scientific societies. She actively reviews for over 25 journals and several international funding agencies, reflecting her global recognition. As a mentor and academic advisor, she supports PhD candidates worldwide. Her research is highly cited, indicating a strong impact in animal physiology and nutrition. Dr. Awad exemplifies excellence in scientific research and academic leadership, making her an outstanding candidate for the Best Researcher Award.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Extensive Academic and Research Experience
    Dr. Awad brings over two decades of high-level experience in veterinary sciences, specifically focused on poultry gut health, intestinal physiology, and mycotoxin research. Her academic journey through top-tier institutions such as Vetmeduni Vienna and the Free University of Berlin reflects strong international credentials.

  2. Highly Cited Publications
    With numerous peer-reviewed articles, several with citation counts exceeding 300, her work demonstrates a significant scientific impact. Topics such as tight junction modulation, probiotic effects, and mycotoxin detoxification are not only highly relevant but also influential in advancing animal health science.

  3. Research Leadership & Recognition
    Awarded multiple prestigious fellowships and international research prizes, including Alexander von Humboldt Awards and the Honorary Professorship (2024) at the University of Lahore, she is globally recognized as a leader in her field.

  4. Global Engagement & Peer Review Contributions
    She is an editorial board member of four international journals, reviewer for 25+ journals and international grant agencies (EU, Hong Kong, Poland, etc.), showcasing her authority and trustworthiness in evaluating high-impact research.

  5. Educational Mentorship
    Serving on PhD advisory boards across institutions in Pakistan and Austria, she actively contributes to nurturing the next generation of scientists.

⚖️ Areas for Improvement:

  1. Wider Dissemination in Interdisciplinary Forums
    While her publications are strong within veterinary and animal science domains, expanding outreach to interdisciplinary audiences (e.g., One Health, bioinformatics) could further increase her visibility and cross-field impact.

  2. Leadership in International Consortia or Projects
    While she participates extensively in research, leading or coordinating large-scale EU/international consortia could further establish her as a strategic scientific leader.

  3. Enhanced Media/Science Communication
    With such influential research, increasing her presence in public science communication platforms, webinars, or educational series could boost her visibility in public and policymaking arenas.

🎓 Education:

Dr. Wageha Awad began her scientific career with a PhD fellowship from the Österreichische Orient-Gesellschaft (2004–2007), undertaking doctoral studies at the University of Veterinary Medicine, Vienna. Her research focused on animal nutrition, leading to significant insights into feed safety and poultry gut health. During her academic development, she pursued advanced postdoctoral studies at the Free University of Berlin, supported by the prestigious Alexander von Humboldt Foundation, where she deepened her expertise in veterinary physiology. She further contributed to the field through a postdoctoral stint at the Institute of Physiology, Pathophysiology, and Biophysics in Vienna. Dr. Awad’s educational background is grounded in rigorous training in both basic and applied sciences, especially in gastrointestinal physiology, feed toxicology, and animal welfare. Her strong academic foundation across leading European institutions has played a pivotal role in shaping her multifaceted research approach in veterinary science.

💼 Professional Experience:

Dr. Awad currently holds the position of Assistant Professor at the Clinic for Poultry and Fish Medicine, Vetmeduni Vienna (since 2019). Prior to this, she served as a Senior Postdoctoral Associate at the same clinic for nearly a decade. Her earlier roles include a postdoctoral researcher at the Institute of Physiology and as an Alexander von Humboldt Fellow at the Free University of Berlin. Her academic journey began as a Scientific Assistant at the Institute of Animal Nutrition, Vetmeduni Vienna. Dr. Awad has actively participated in international research collaborations and has held advisory roles on PhD committees in Pakistan. Her dynamic career reflects a blend of research, teaching, and international academic engagement. Her work has contributed to understanding gut microbiota, dietary toxins, and poultry nutrition, earning her high regard in veterinary circles. Her scientific output and mentorship continue to influence veterinary physiology and animal health globally.

🏅 Awards and Honors:

Dr. Wageha Awad has received numerous prestigious awards recognizing her scientific excellence. In 2024, she was appointed Honorary Professor at the University of Lahore, Pakistan. She has earned multiple research awards, including the Armin Tschermak von Seysenegg Award (2018), Science Award for Third-party Funds (2017), and two Alexander von Humboldt Research Awards (2007–2009, 2014). Her early research achievements were recognized by the Brigitte Gedek Award for Mycotoxin Research (2008), and she received the H. Wilhelm Schaumann Stiftung Promotion Award in 2013. She was also honored with the Best Poster Award at the 8th International Conference of the European Society of Veterinary and Comparative Nutrition in 2004. These accolades underscore her impactful contributions to veterinary medicine, particularly in gut health, feed additives, and toxicology. Her international recognition and consistent track record of scientific excellence make her a strong nominee for the Best Researcher Award.

🔬 Research Focus:

Dr. Awad’s research centers on intestinal physiology and gut health in poultry, with a particular focus on the structure and function of the epithelial barrier and host-pathogen interactions. Her studies explore the effects of enteric pathogens like Campylobacter, Salmonella, and E. coli on gut integrity and immune responses. She investigates the influence of feed additives, mycotoxins, probiotics, and synbiotics on animal health and performance. Her work also examines microbiota modulation and the physiological mechanisms behind nutrient absorption and barrier function. With over a decade of laboratory and field experience, her innovative studies have led to new strategies for enhancing gut health and preventing disease in poultry through nutrition-based approaches. Her multidisciplinary research integrates veterinary physiology, microbiology, immunology, and nutrition—contributing to the development of safer, more effective feeding practices. Dr. Awad’s contributions are widely cited, making her a leading voice in animal health and poultry science research.

📚 Publications Top Notes:

📖 Effects of dietary inclusion of probiotic and synbiotic on broiler growth and intestinal histomorphology
📖 Indigenous bacteria and bacterial metabolic products in the gastrointestinal tract of broilers
📖 Enteric pathogens and their disruption of the intestinal barrier via tight junction alteration in chickens
📖 Probiotic addition to broiler diets contaminated with deoxynivalenol: performance and villi histology
📖 Intestinal structure and function in broilers fed synbiotics (Enterococcus faecium & oligosaccharides)
📖 Impacts of feed contaminant deoxynivalenol on poultry and swine intestines
📖 Strategies for detoxifying deoxynivalenol in animal feed via microbial biodegradation
📖 Efficacy of an avian-specific probiotic in reducing Campylobacter jejuni colonization in broilers
📖 Age-related gut microbiome shifts in broilers and effects of Campylobacter jejuni infection
📖 Campylobacter infection modulates intestinal barrier function in chickens

📝 Conclusion:

Ass. Prof. Dr. Wageha Awad is an exceptional and highly deserving candidate for the Best Researcher Award. Her academic excellence, publication impact, and global collaborations reflect an accomplished researcher who has made significant contributions to poultry physiology, gut health, and food safety. She has built a sustainable and far-reaching research portfolio, inspiring peers and young researchers alike. With continued focus on global leadership roles and interdisciplinary collaborations, she is poised to further elevate her impact in veterinary sciences and beyond.